Standard Peripheral Vascular Device Market Size, Share & Trends Analysis | Global | 2025-2032 | MedSuite | Includes: Inferior Vena Cava Filters, Carotid Shunts, Introducer Sheaths, and 4 more

Product Description

Overall, the global standard peripheral vascular device market was valued at $4.3 billion in 2025. This is expected to increase over the forecast period at a CAGR of 4.2% to reach over $5.7 billion.

The full report suite on the global market for standard peripheral vascular (PV) devices includes inferior vena cava filters, carotid shunts, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths, vascular closure devices (VCDs) and transcatheter embolization devices.

Data Types Included

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Procedure Numbers
• Market Drivers & Limiters
• Market Forecasts Until 2032, and Historical Data to 2022
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

Global Standard Peripheral Vascular Device Market Trends

A significant trend in the VCD market is the rising adoption of non-invasive and extravascular closure technologies, driven by the ongoing shift toward radial access and same-day discharge procedures. As peripheral interventions increasingly transition to outpatient and office-based lab (OBL) settings, demand is growing for closure devices that reduce complications, shorten recovery times and enable quicker patient mobilization. Plug-based and adhesive-based systems are gaining momentum due to their simplicity, efficiency, and strong safety profiles when compared to traditional suture-based methods. This shift is expected to accelerate further as clinical guidelines and reimbursement frameworks continue to favor shorter hospital stays and outpatient care models.

Global Standard Peripheral Vascular Device Market Share Insights

• Terumo held the leading position in the global standard peripheral vascular device market in 2025, supported by strong performance in the guidewire and vascular closure device (VCD) segments. The company also ranked as the top competitor in the diagnostic and interventional catheter and introducer sheath markets. Terumo maintained dominance in the hydrophilic guidewire segment through its Glidewire® product line, which features a kink-resistant nitinol core and a radiopaque tungsten jacket. Variants such as the Glidewire® GT and Glidewire® Gold provide enhanced flexibility and improved tip visibility. To maintain its competitive edge, Terumo has implemented selective price reductions for guidewires in certain regions. The company further reinforced its global leadership in the VCD segment following its 2016 acquisition of Angio-Seal™ and FemoSeal™ from St. Jude Medical, a transaction resulting from antitrust requirements related to Abbott’s acquisition of St. Jude.
• Boston Scientific held the second-largest share in the global standard peripheral vascular device market in 2025. The company’s $7.4 billion acquisition of BTG in 2019 substantially broadened its product portfolio, establishing Boston Scientific as a leader in transcatheter embolization technologies. Additionally, the company received FDA approval for its VICI® venous stent and continues to maintain a strong presence through its established Wallstent® product line. In recent years, Boston Scientific has placed growing emphasis on developing solutions for oncology-related vascular applications and the treatment of deep vein thrombosis (DVT).
• Abbott Vascular held the third-largest share of the global standard peripheral vascular device market in 2025, primarily driven by its leadership in the large-bore VCD segment. The company dominated the overall VCD market with its suture-mediated closure systems, StarClose™, Perclose® and ProStar® XL, which use needles and knots to seal arterial access sites. Abbott has continuously refined these devices to improve procedural stability, user convenience, and minimize inflammation. Although the company maintained a near-monopoly in the large-bore invasive VCD category through 2024, its market position is expected to face pressure as emerging single-device closure technologies enter the field, even though these alternatives have yet to achieve substantial market adoption.

Global Standard Peripheral Vascular Device Market Segmentation Summary

• Inferior Vena Cava Filter Market – Further Segmented Into:
  • Device Type: IVCF, and IVCF Retrieval Device.
• Carotid Shunt Market
• Diagnostic and Interventional Catheter Market – Further Segmented Into:
  • Device Type: Diagnostic Catheter, and Support Catheter.
• Diagnostic & Interventional Guidewire Market – Further Segmented Into:
  • Device Type: Standard, and Hydrophilic.
• Introducer Sheath Market
• Vascular Closure Device Market – Further Segmented Into:
  • Device Type: Non-Invasive, and Invasive.
• Transcatheter Embolization Market – Further Segmented Into:
  • Device Type: Particle, and Coil.

Research Scope Summary